106 related articles for article (PubMed ID: 29059872)
1. Nanoparticle-based delivery of an anti-proliferative metal chelator to tumor cells.
Kang YJ; Kuo CF; Majd S
Annu Int Conf IEEE Eng Med Biol Soc; 2017 Jul; 2017():309-312. PubMed ID: 29059872
[TBL] [Abstract][Full Text] [Related]
2. Development and in vitro assessment of an anti-tumor nano-formulation.
Holley CK; Kang YJ; Kuo CF; Abidian MR; Majd S
Colloids Surf B Biointerfaces; 2019 Dec; 184():110481. PubMed ID: 31539751
[TBL] [Abstract][Full Text] [Related]
3. Fabrication and Optimization of Dp44mT-Loaded Nanoparticles.
Holley CK; Alkhalifah S; Majd S
Annu Int Conf IEEE Eng Med Biol Soc; 2018 Jul; 2018():5733-5736. PubMed ID: 30441638
[TBL] [Abstract][Full Text] [Related]
4. Examining the Anti-Tumor Activity of Dp44mT-Loaded Nanoparticles In Vitro.
Holley CK; Majd S
Annu Int Conf IEEE Eng Med Biol Soc; 2020 Jul; 2020():5029-5032. PubMed ID: 33019116
[TBL] [Abstract][Full Text] [Related]
5. Optimization of the Single Emulsion Method for Encapsulation of a Cancer Drug in Nanoparticles.
Holley CK; Sinquefield B; Majd S
Annu Int Conf IEEE Eng Med Biol Soc; 2019 Jul; 2019():1078-1081. PubMed ID: 31946081
[TBL] [Abstract][Full Text] [Related]
6. The Anticancer Agent, Di-2-Pyridylketone 4,4-Dimethyl-3-Thiosemicarbazone (Dp44mT), Up-Regulates the AMPK-Dependent Energy Homeostasis Pathway in Cancer Cells.
Krishan S; Richardson DR; Sahni S
Biochim Biophys Acta; 2016 Dec; 1863(12):2916-2933. PubMed ID: 27639899
[TBL] [Abstract][Full Text] [Related]
7. Tumor Targeted Delivery of an Anti-Cancer Therapeutic: An In Vitro and In Vivo Evaluation.
Kang YJ; Holley CK; Abidian MR; Madhankumar AB; Connor J; Majd S
Adv Healthc Mater; 2021 Jan; 10(2):e2001261. PubMed ID: 33191612
[TBL] [Abstract][Full Text] [Related]
8. Translocator protein ligand-PLGA conjugated nanoparticles for 5-fluorouracil delivery to glioma cancer cells.
Laquintana V; Denora N; Lopalco A; Lopedota A; Cutrignelli A; Lasorsa FM; Agostino G; Franco M
Mol Pharm; 2014 Mar; 11(3):859-71. PubMed ID: 24410438
[TBL] [Abstract][Full Text] [Related]
9. Biomimetic Dp44mT-nanoparticles selectively induce apoptosis in Cu-loaded glioblastoma resulting in potent growth inhibition.
Ismail M; Yang W; Li Y; Wang Y; He W; Wang J; Muhammad P; Chaston TB; Rehman FU; Zheng M; Lovejoy DB; Shi B
Biomaterials; 2022 Oct; 289():121760. PubMed ID: 36044788
[TBL] [Abstract][Full Text] [Related]
10. Fabrication of curcumin encapsulated PLGA nanoparticles for improved therapeutic effects in metastatic cancer cells.
Yallapu MM; Gupta BK; Jaggi M; Chauhan SC
J Colloid Interface Sci; 2010 Nov; 351(1):19-29. PubMed ID: 20627257
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional regulation of the cyclin-dependent kinase inhibitor, p21
Moussa RS; Kovacevic Z; Bae DH; Lane DJR; Richardson DR
Biochim Biophys Acta Gen Subj; 2018 Mar; 1862(3):761-774. PubMed ID: 29032246
[TBL] [Abstract][Full Text] [Related]
12. Complex forming competition and in-vitro toxicity studies on the applicability of di-2-pyridylketone-4,4,-dimethyl-3-thiosemicarbazone (Dp44mT) as a metal chelator.
Gaál A; Orgován G; Polgári Z; Réti A; Mihucz VG; Bősze S; Szoboszlai N; Streli C
J Inorg Biochem; 2014 Jan; 130():52-8. PubMed ID: 24176919
[TBL] [Abstract][Full Text] [Related]
13. Lysosomal membrane stability plays a major role in the cytotoxic activity of the anti-proliferative agent, di-2-pyridylketone 4,4-dimethyl-3-thiosemicarbazone (Dp44mT).
Gutierrez EM; Seebacher NA; Arzuman L; Kovacevic Z; Lane DJ; Richardson V; Merlot AM; Lok H; Kalinowski DS; Sahni S; Jansson PJ; Richardson DR
Biochim Biophys Acta; 2016 Jul; 1863(7 Pt A):1665-81. PubMed ID: 27102538
[TBL] [Abstract][Full Text] [Related]
14. Enhanced stimulation of anti-breast cancer T cells responses by dendritic cells loaded with poly lactic-co-glycolic acid (PLGA) nanoparticle encapsulated tumor antigens.
Iranpour S; Nejati V; Delirezh N; Biparva P; Shirian S
J Exp Clin Cancer Res; 2016 Oct; 35(1):168. PubMed ID: 27782834
[TBL] [Abstract][Full Text] [Related]
15. Quantitative analysis of the anti-proliferative activity of combinations of selected iron-chelating agents and clinically used anti-neoplastic drugs.
Potuckova E; Jansova H; Machacek M; Vavrova A; Haskova P; Tichotova L; Richardson V; Kalinowski DS; Richardson DR; Simunek T
PLoS One; 2014; 9(2):e88754. PubMed ID: 24586383
[TBL] [Abstract][Full Text] [Related]
16. Docetaxel-loaded PLGA and PLGA-PEG nanoparticles for intravenous application: pharmacokinetics and biodistribution profile.
Rafiei P; Haddadi A
Int J Nanomedicine; 2017; 12():935-947. PubMed ID: 28184163
[TBL] [Abstract][Full Text] [Related]
17. Surface modification of PLGA nanoparticles with biotinylated chitosan for the sustained in vitro release and the enhanced cytotoxicity of epirubicin.
Chen H; Xie LQ; Qin J; Jia Y; Cai X; Nan W; Yang W; Lv F; Zhang QQ
Colloids Surf B Biointerfaces; 2016 Feb; 138():1-9. PubMed ID: 26638176
[TBL] [Abstract][Full Text] [Related]
18. Formulation of Anti-miR-21 and 4-Hydroxytamoxifen Co-loaded Biodegradable Polymer Nanoparticles and Their Antiproliferative Effect on Breast Cancer Cells.
Devulapally R; Sekar TV; Paulmurugan R
Mol Pharm; 2015 Jun; 12(6):2080-92. PubMed ID: 25880495
[TBL] [Abstract][Full Text] [Related]
19. Polymeric Nano-Encapsulation of Curcumin Enhances its Anti-Cancer Activity in Breast (MDA-MB231) and Lung (A549) Cancer Cells Through Reduction in Expression of HIF-1α and Nuclear p65 (Rel A).
Khan MN; Haggag YA; Lane ME; McCarron PA; Tambuwala MM
Curr Drug Deliv; 2018 Feb; 15(2):286-295. PubMed ID: 29065834
[TBL] [Abstract][Full Text] [Related]
20. Preparation, characterization, and anticancer efficacy of evodiamine-loaded PLGA nanoparticles.
Zou L; Chen F; Bao J; Wang S; Wang L; Chen M; He C; Wang Y
Drug Deliv; 2016; 23(3):908-16. PubMed ID: 24904975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]